Clinical study of compliance with orally administered raloxifene [Evista; Daiichi Sankyo] in women with postmenopausal osteoporosis.
Latest Information Update: 10 Jun 2009
At a glance
- Drugs Raloxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
Most Recent Events
- 10 Jun 2009 New trial record.
- 19 May 2009 Results have been presented at the 8th European Congress on Menopause according to Daiichi Sankyo media release; results were also reported in the media release.